Lyon, France

Rémi Meyrueix

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Technology LLC. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rémi Meyrueix. Retrieved from https://idiyas.com/inventor/randeacutemi-meyrueix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rémi Meyrueix: Innovator in Plant Biotechnology

Introduction

Rémi Meyrueix is a notable inventor based in Lyon, France. He has made significant contributions to the field of plant biotechnology. His work focuses on enhancing the biological effectiveness of chemical substances in plants.

Latest Patents

Rémi Meyrueix holds a patent for a process and compositions that promote the biological effectiveness of exogenous chemical substances in plants. This innovation is crucial for improving agricultural practices and enhancing crop yields.

Career Highlights

He is currently associated with Monsanto Technology LLC, a leading company in agricultural biotechnology. His role involves research and development aimed at creating more effective agricultural solutions.

Collaborations

Rémi has collaborated with notable colleagues, including Nathan J Bryson and Olivier Soula. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Rémi Meyrueix is a prominent figure in plant biotechnology, with a focus on enhancing the effectiveness of chemical substances in agriculture. His contributions are vital for the future of sustainable farming practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…